IRIS Accounts Production v24.3.0.553 10844861 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 4729 6804 4000 12854 10312 10779 11041 4729 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108448612023-06-30108448612024-06-30108448612023-07-012024-06-30108448612022-06-30108448612022-07-012023-06-30108448612023-06-3010844861ns15:EnglandWales2023-07-012024-06-3010844861ns14:PoundSterling2023-07-012024-06-3010844861ns10:Director12023-07-012024-06-3010844861ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3010844861ns10:SmallEntities2023-07-012024-06-3010844861ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3010844861ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3010844861ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3010844861ns10:FullAccounts2023-07-012024-06-3010844861ns10:OrdinaryShareClass12023-07-012024-06-3010844861ns10:OrdinaryShareClass22023-07-012024-06-301084486142ns10:Director22023-06-301084486142ns10:Director22022-06-301084486142ns10:Director22023-07-012024-06-301084486142ns10:Director22022-07-012023-06-301084486142ns10:Director22024-06-301084486142ns10:Director22023-06-3010844861ns5:CurrentFinancialInstruments2024-06-3010844861ns5:CurrentFinancialInstruments2023-06-3010844861ns5:ShareCapital2024-06-3010844861ns5:ShareCapital2023-06-3010844861ns5:RetainedEarningsAccumulatedLosses2024-06-3010844861ns5:RetainedEarningsAccumulatedLosses2023-06-3010844861ns10:RegisteredOffice2023-07-012024-06-3010844861ns5:FurnitureFittings2023-06-3010844861ns5:ComputerEquipment2023-06-3010844861ns5:FurnitureFittings2023-07-012024-06-3010844861ns5:ComputerEquipment2023-07-012024-06-3010844861ns5:FurnitureFittings2024-06-3010844861ns5:ComputerEquipment2024-06-3010844861ns5:FurnitureFittings2023-06-3010844861ns5:ComputerEquipment2023-06-3010844861ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-06-3010844861ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3010844861ns10:OrdinaryShareClass12024-06-3010844861ns10:OrdinaryShareClass22024-06-3010844861ns10:Director22023-07-012024-06-30108448611ns10:Director12023-06-30108448611ns10:Director12022-06-30108448611ns10:Director12023-07-012024-06-30108448611ns10:Director12022-07-012023-06-30108448611ns10:Director12024-06-30108448611ns10:Director12023-06-30
REGISTERED NUMBER: 10844861 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th June 2024

for

Carr Green Medical Limited

Carr Green Medical Limited (Registered number: 10844861)






Contents of the Financial Statements
for the Year Ended 30th June 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Carr Green Medical Limited (Registered number: 10844861)

Balance Sheet
30th June 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,201 1,838

CURRENT ASSETS
Debtors 5 3,142 3,439
Investments 6 78,302 69,381
Cash at bank 79,608 46,843
161,052 119,663
CREDITORS
Amounts falling due within one year 7 20,294 12,853
NET CURRENT ASSETS 140,758 106,810
TOTAL ASSETS LESS CURRENT
LIABILITIES

143,959

108,648

PROVISIONS FOR LIABILITIES 608 -
NET ASSETS 143,351 108,648

CAPITAL AND RESERVES
Called up share capital 8 200 200
Retained earnings 143,151 108,448
SHAREHOLDERS' FUNDS 143,351 108,648

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26th November 2024 and were signed on its behalf by:




Professor B J Parker - Director


Carr Green Medical Limited (Registered number: 10844861)

Notes to the Financial Statements
for the Year Ended 30th June 2024

1. COMPANY INFORMATION

Carr Green Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10844861

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers - 25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Carr Green Medical Limited (Registered number: 10844861)

Notes to the Financial Statements - continued
for the Year Ended 30th June 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st July 2023 - 5,138 5,138
Additions 1,441 1,099 2,540
At 30th June 2024 1,441 6,237 7,678
DEPRECIATION
At 1st July 2023 - 3,300 3,300
Charge for year 210 967 1,177
At 30th June 2024 210 4,267 4,477
NET BOOK VALUE
At 30th June 2024 1,231 1,970 3,201
At 30th June 2023 - 1,838 1,838

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Trade debtors 3,142 3,402
Deferred tax asset - 37
3,142 3,439

6. CURRENT ASSET INVESTMENTS
30.6.24 30.6.23
£    £   
Other 78,302 69,381

Market value of listed investments at 30 June 2024 - £78,302 (2023 - £69,381). The current asset investments represents holdings in listed shares. The listed shares are recognised at market value.

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Tax 8,296 7,181
Directors' current accounts 11,041 4,729
Accrued expenses 957 943
20,294 12,853

Carr Green Medical Limited (Registered number: 10844861)

Notes to the Financial Statements - continued
for the Year Ended 30th June 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.24 30.6.23
value: £    £   
100 Ordinary A 1 100 100
100 Ordinary B 1 100 100
200 200

The ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in respect of dividend and capital distribution rights.

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30th June 2024 and 30th June 2023:

30.6.24 30.6.23
£    £   
Professor B J Parker and Dr G Parker
Balance outstanding at start of year (4,729 ) (6,804 )
Amounts advanced 4,000 12,854
Amounts repaid (10,312 ) (10,779 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (11,041 ) (4,729 )

The loan is repayable on demand and no interest was charged during the year.

10. CONTROL

The ultimate controlling party is Dr B Parker by virtue of holding 100% of the voting share capital.